Concordant with our results, Mona’s recent study demonstrated that sitagliptin suppresses inflammation by decreasing HMGB1-mediated TLR4/NF-κB signalling in a rat obesity model [30]. Here, HMGB1 is linked to obesity due to melanocortin 4 receptor deficiency.